What's the suggested lipitor liver test frequency?

Recommended liver‑function testing for patients on Lipitor (atorvastatin)

| Step | What to do | When |
|------|------------|------|
| Baseline | Check AST, ALT, and total bilirubin (or an LFT panel) before starting therapy. | At the first prescription visit. |
| Early monitoring | Repeat a liver‑function test. | 4–12 weeks after starting therapy. |
| Long‑term monitoring | Check LFTs annually, or sooner if:
• The patient is >40 years old or has risk factors for liver disease (e.g., chronic alcohol use, viral hepatitis, metabolic syndrome).
• The patient develops symptoms suggestive of hepatic injury (jaundice, abdominal pain, fatigue, dark urine). | Every 12 months, or sooner if above red‑flag symptoms appear. |

Key points

• Routine LFTs after the initial check are not mandatory for all patients, but many clinicians continue yearly testing or test when risk factors or symptoms emerge.
  
• If any abnormal LFTs appear (e.g., ALT or AST >3× the upper limit of normal, or >1× if the patient has pre‑existing liver disease), the drug should be held and reassessed by a healthcare provider.
  
• Most serious hepatic reactions are rare. Monitoring helps catch early signs of injury, but the evidence that routine yearly checks improve outcomes is limited. Many professional guidelines (e.g., ACC/AHA, ESC, NICE) recommend baseline and 4–12 week testing, then yearly or as clinically indicated.
  
  Bottom line: Start with a baseline LFT, repeat it at 4–12 weeks, and then check yearly (or earlier if the patient is older, has liver disease risk factors, or develops symptoms). Always follow the specific instructions from your prescribing clinician.